Research & News Research & NewsAllBlogNewsJan 16, 2026From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug developmentNewsJan 9, 2026With new AI deal, Eli Lilly and Chai Discovery kick off a 'year of deployment' in pharmaNewsJan 9, 2026Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics DiscoveryNewsDec 15, 2025Chai Discovery becomes newest AI unicorn, raising $130M Series B at $1.3B valuationNewsDec 15, 2025Chai Discovery Announces $130 Million Series B To Transform Molecular Discovery NewsDec 15, 2025OpenAI-Backed Chai Discovery Raises $130 Million for AI-Designed MoleculesNewsDec 15, 2025Series BBlogNov 19, 2025Drug-like antibody design against challenging targets with atomic precisionBlogSep 19, 2025The Endpoints 11: OpenAI-backed Chai Discovery’s brainiac quartet aims to design drugs on the computerNewsAug 6, 2025OpenAI-backed Chai raises $70mn for AI-driven drug discoveryNewsAug 6, 2025OpenAI-backed biotech Chai Discovery raises $70M Series ANewsAug 6, 2025Chai Discovery Announces $70 million Series A To Transform Molecular DesignNewsAug 6, 2025Series ABlogJun 30, 2025OpenAI-backed startup releases new AI models, claiming top performance in making antibodiesNewsJun 30, 2025Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AINewsJun 30, 2025Introducing Chai-2: Zero-shot antibody design in a 24-well plateBlogJun 9, 2025New OpenBind consortium to make the UK a leader in AI-driven drug discoveryNewsSep 16, 2024Drug discovery platform raises $30M as AI health-tech companies continue to attract investorsNewsSep 12, 2024OpenAI-backed start-up unveils Chai-1 AI model for drug discoveryNewsSep 9, 2024OpenAI, Thrive Capital Back Six-Month-Old AI Drug Discovery StartupNewsSep 9, 2024Introducing Chai-1: Decoding the molecular interactions of lifeBlogSep 9, 2024SeedBlog© 2026 All rights reserved.Contact UsTerms of ServicePrivacy Policy